Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry

被引:7
|
作者
Hikosaka, Keisuke [1 ]
Noritake, Hidenao [1 ,2 ]
Kimura, Wataru [1 ]
Sultana, Nishat [1 ]
Sharkar, Mohammad T. K. [1 ]
Tagawa, Yoh-ichi [3 ]
Uezato, Tadayoshi [1 ]
Kobayashi, Yoshimasa [2 ]
Wakita, Takaji [4 ]
Miura, Naoyuki [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Biochem, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Div 2, Dept Internal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[3] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Kanagawa 2268501, Japan
[4] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan
来源
BIOMEDICAL RESEARCH-TOKYO | 2011年 / 32卷 / 02期
关键词
HEPATITIS-C-VIRUS; E2; GLYCOPROTEIN; INFECTION; BINDING; CELLS; STEP; ENDOCYTOSIS; REQUIRES; MICE;
D O I
10.2220/biomedres.32.143
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
No suitable mouse model is available for studying chronic liver disease caused by hepatitis C virus (HCV). CD81, claudin-1, scavenger receptor class B type and occludin were recently reported to be the important factors in HCV entry into hepatocytes. We made transgenic mice (Alb-CCSO) expressing the four human proteins and examined whether HCV from a patient serum or HCV pseudoparticles (HCVpp) were capable of infecting them. HCV was not detected in the mouse serum after injecting the mice with HCV from a patient serum. We also found no indications of HCVpp entry into primary hepatocytes from Alb-CCSO mice. In addition, HCV-infectible Hep3B cells were fused with HCV-resistant primary mouse hepatocytes and the fused cells showed 35-fold lower infectivity compared to wild-type Hep3B cells, indicating that primary mouse hepatocytes have the inhibitory factor(s) in HCVpp entry. Our results suggest that the expression of the human factors does not confer susceptibility to HCV entry into the liver.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 5 条
  • [1] Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection
    Masciopinto, F
    Freer, G
    Burgio, VL
    Levy, S
    Galli-Stampino, L
    Bendinelli, M
    Houghton, M
    Abrignani, S
    Uematsu, Y
    VIROLOGY, 2002, 304 (02) : 187 - 196
  • [2] Tupaia CD81, SR-BI, Claudin-1, and Occludin Support Hepatitis C Virus Infection
    Tong, Yimin
    Zhu, Yongzhe
    Xia, Xueshan
    Liu, Yuan
    Feng, Yue
    Hua, Xian
    Chen, Zhihui
    Ding, Hui
    Gao, Li
    Wang, Yongzhi
    Feitelson, Mark A.
    Zhao, Ping
    Qi, Zhong-Tian
    JOURNAL OF VIROLOGY, 2011, 85 (06) : 2793 - 2802
  • [3] In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
    Davis, Christopher
    Harris, Helen J.
    Hu, Ke
    Drummer, Heidi E.
    McKeating, Jane A.
    Mullins, Jonathan G. L.
    Balfe, Peter
    CELLULAR MICROBIOLOGY, 2012, 14 (12) : 1892 - 1903
  • [4] Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
    Bitzegeio, Julia
    Bankwitz, Dorothea
    Hueging, Kathrin
    Haid, Sibylle
    Brohm, Christiane
    Zeisel, Mirjam B.
    Herrmann, Eva
    Iken, Marcus
    Ott, Michael
    Baumert, Thomas F.
    Pietschmann, Thomas
    PLOS PATHOGENS, 2010, 6 (07) : 1 - 15
  • [5] Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes
    Ramanathan, Aarti
    Gusarova, Viktoria
    Stahl, Neil
    Gurnett-Bander, Anne
    Kyratsous, Christos A.
    PLOS ONE, 2016, 11 (04):